
Loading, please wait...

Loading, please wait...

AIIMS Delhi researchers have made a significant breakthrough in Gut-Bone Axis Research. They discovered that a molecule produced in the gut helps protect bones from inflammation-driven damage. This finding offers a promising new path to tackle osteoporosis. Consequently, doctors may soon look beyond traditional calcium supplements to maintain skeletal health. Bone strength often depends on a complex balance of cellular activity influenced by the microbiome.
Researchers specifically focused on deoxycholic acid (DCA). This secondary bile acid is a compound naturally produced by gut bacteria. Notably, the team found that DCA levels are significantly lower in patients suffering from osteoporosis and bone loss. Furthermore, the molecule demonstrates a dual effect on bone metabolism. It effectively suppresses bone-resorbing osteoclasts while boosting bone-forming osteoblasts. This balance is vital for preventing the fragility associated with aging.
The study, published in Biomedicine & Pharmacotherapy, highlights the importance of the Gut-Bone Axis Research. In animal models, DCA significantly reduced bone damage caused by inflammation. Moreover, the compound strengthened the gut lining and helped restore healthy bacterial populations. Therefore, maintaining a healthy gut microbiome might be as crucial as physical activity for bone density. The researchers observed that DCA regulates key pathways that control how bones form and break down over time.
Dr. Rupesh K. Srivastava, who led the study at AIIMS, suggests two future treatment strategies. Physicians could eventually supplement DCA directly or use probiotics to enhance the gut bacteria that produce it. However, clinical trials in humans are necessary before these findings can change standard practice. For now, the message remains clear. Caring for your gut is vital for long-term bone health. Additionally, this research could reshape how specialists treat various metabolic bone diseases.
Q1: What is the gut-bone axis?
The gut-bone axis is the physiological link between the gut microbiome and bone metabolism. Molecules like bile acids produced in the gut can influence the activity of bone-forming and bone-resorbing cells.
Q2: How does deoxycholic acid (DCA) improve bone strength?
DCA improves bone strength by reducing inflammatory signals that cause bone loss. Simultaneously, it increases the production of osteoblasts, which are the cells responsible for building new bone tissue.
Q3: Can patients start taking DCA supplements now?
No, the current findings are based on animal studies. Dr. Srivastava cautions that human clinical trials are required to ensure safety and efficacy before it can be recommended for patient use.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


AIIMS Delhi researchers find deoxycholic acid (DCA) from gut bacteria protects against osteoporosis by boosting bone formation and reducing inflammation....
5 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

Odisha has established India's first state-level clinical protocol specifically tailored for pregnant women with sickle cell disease. Developed with NHM and UNICEF, the framework provides structured antenatal screening, crisis mitigation, standardized referral pathways, and specialized interdisciplinary care.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today